Previous studies have indicated that the abnormal expression of PTK6 is related to a variety of malignant tumors, including breast cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, prostate cancer, and colorectal cancer [21, 24, 38–40]. This evidence concerns the gene PTK6 and breast carcinoma.